# EMEND

NDC: 0006-3061
Generic name: FOSAPREPITANT DIMEGLUMINE
Labeler / Manufacturer: Merck Sharp & Dohme LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes: INTRAVENOUS
Marketing started: 20170203

FDA application: NDA022023

## Active ingredients

- FOSAPREPITANT DIMEGLUMINE: 150 mg/5mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0006-3061"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0006-3061
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8d66803a-6811-4c29-9c57-e16acfa87f21